Mark Gallo Email & Phone Number

Miami, Florida, United States

Accountable for marketing and promoting products to hepatologists, nephrologists, critical care physicians, and intensivists calling on transplant centers and hospitals throughout the South Florida region. Educate and present complex clinical disease state information to advance diagnosis and treatment. ✔Consistently meet or exceed sales objectives/quota and ranked #2 in the region. ✔Develop KOLs and implement programs consistent with product strategy to drive sales results.✔Devise and implement plans to address distribution channel, access, competition, and market challenges to positively impact sales.✔Drove adoption of the product portfolio and gained formulary wins at XXXXX and XXXXX.✔Successfully launched Terlivaz launch and captured leading market share.✔Collaborate with Market Access, National Account Managers, and MSLs to advance sales and coordinate speaker programs.✔Selected to represent the company at national conferences and congresses.

Championed the establishment and ongoing development of critical relationships with specialty care professionals to promote Astra Zeneca as a market leader in the Fort Lauderdale and Hollywood territory. Marketed Brilinta and Farxiga to cardiologists, interventional cardiologists, clinical cardiologists, and hospitals. ✔Ranked #2 in the country for Brilinta and 4th in the region for hospital sales out of 25 regions.✔Successfully attained 112% to plan for Farxiga.✔Gained a formulary win for Broward Health System for Farxiga.✔Significantly increased the breadth and depth of Farxiga within the region, capturing leading market share.✔Grew Farxiga to become the #1 prescribed SGLT2 class drug.

Championed the establishment and ongoing development of critical relationships with specialty care professionals to promote Merck as a market leader throughout the Tri-County territory in the Southeast Region. Responsible for brand marketing a product portfolio of multiple injectables to infectious disease physicians, gastroenterologists, hospital pharmacists, specialty pharmacies, hematology, oncology, case managers, nurse managers, and hospitalists. Significant emphasis on buy and bill contracts, as well as assisting with prior authorizations and reimbursement to ensure patient access to medications. Products represented included Dificid, Zinplava, and Prevymis for Clostridium Difficile/antiviral. Built this territory from the ground up. Select Accomplishments ▬▬▬▬▬▬▬▬▬▬▬✔2020 signed and closed and signed a contract during pandemic on mainly virtual and digital communication attaining formulary for Dificid for the entire Broward Health System.✔2019 collaborated with account managers to bring Zinplava and Dificid to one of the largest Gastro Health GI practices in the country.✔2019 organized a speaker program with entire SESHP’s pharmacy network to key pharmacists for their continuing education. ✔Awarded the Vice President’s Club Award, representing the top 10% of the sales force in 2019 for exhibiting outstanding sales performance and exceptional leadership.* continued below *

* continued from above *✔2018 successfully launched Prevymis and had protocol set with BMT Memorial Cancer Center within one month. ✔2018 launched new guidelines for IDSA clinical practice guidelines for Dificid.✔2017 obtained Dificid formulary at Memorial Hospital Health System, Boca Raton, Delray, FMC, Martin Memorial Health System and Indiana River Hospital. Worked with specialty pharmacy and inpatient pharmacy to educate on product and reestablish im-portance of this market for the hospitals. ✔2017 launched one of Merck’s first monoclonal antibody for recurrence clostridium difficile, Zinplava. In 2018, Boca Raton Hospital agreed to infusion Zinplava in an outpatient product.✔Received numerous Awards of Excellence for flawless execution of market development opportunities. ✔Continually differentiated in the top or upper-level tier of all Hospital Representatives at both the regional and national level.Leadership Engagement ▬▬▬▬▬▬▬▬▬▬▬✔2020 served as the Operation Liaison for district point. ✔2019 Policy and Continuing Education district point. ✔Delivered proactive sales techniques, built integrated programs and serviced delivery directives that met long- and short-term objectives. Captured record-breaking revenues, new pipeline/lead generations across three counties.✔Successful in securing IDN and hospital system formulary adoption for assigned product portfolio.✔Attained highest NRx share change for multiple products, team building, and flawless internal collaboration and integration.

Promoted a diverse product portfolio infectious disease, critical care, pulmonary physicians, microbiologists, hospital pharmacists, specialty pharmacies, case managers, nurse managers, and surgeons on a variety of antibiotics and antiviral pharmaceuticals. Products represented included Primaxin, Invanz, Cancidas, Pneumovax 23, Antibiotics, antivirals, and Vaccines. Select Accomplishments ▬▬▬▬▬▬▬▬▬▬▬✔2014 attained 103% to goals for Invanz; 105% to goal for Noxafil; and 105% to goal for Pneumovax 23✔2012 attained 111% to goal for Cancidas and 206% to goal for Pneumovax 23.✔2011 served as contract point for district and mentor to new legacy reps regarding credentialing.✔2011 attained 138% to goal for Pneumovax 23 and ranked #1 in the nation. 120% to goal for Invanz and ranked #7 in the nation. Attained 126% for Noxafil. ✔2010 attained 105% to goal for Primaxin, 142.2% to goal for Invanz, and 111% to goal for Avelox.✔2009 attained 126.4% to goal for Primaxin, 103.6% to goal for Vytorin, and 104.8% to goal for Cancidas.✔2008 attained 155.4% to goal for Invanz.✔2007 attained 119.7% to goal for Cancidas. ✔2006 secured a contract for Jackson Memorial Hospital System for Primaxin.✔2006 Attained Invanz - 104.5% to goal and Primaxin - 116.2% to goal. * continued below *

* continued from above *Leadership Engagement ▬▬▬▬▬▬▬▬▬▬▬✔Awarded the Vice President’s Club Award, representing the top 10% of the sales force in 2011 and 2008 for exhibiting outstanding sales performance and exceptional leadership. ✔Issued company stock options that recognized the Top 5% of Sales Representatives based on financial results, business execution, and leadership.✔Recognized at the region level for Execution Excellence, contributing to outstanding market share increases for Invanz for the first quarter of 2005 in spite of territory vacancies.✔Attained formulary wins for Primaxin with North Shore Hospital and Jackson North (win back).✔Secured formulary win for Primaxin with Palm Springs Hospital and Aventura Hospital.

Managed a broad territory within Miami Beach and North Miami establishing relationships with cardiologists, primary care physicians, pain management physicians, and surgeons. Products represented included Cozaar/Hyzaar, Zocor, Maxalt, and Vioxx.✔Won Most Valuable Person in the District and The Senior Executive Leader Award for exhibiting exemplary leadership skills.✔2004 point person for bi weekly teleconferences and point lead for the SAVE contract for the district.✔2003 MVP Super District Award (selected by peers). ✔2003 District Point for Diversity and Inclusion. ✔2003 Vioxx exceeded plan over 105%, attained 147.5% to goal for Primaxin and attained 40% Zocor market share in a very com-petitive class. ✔2002 mentor for new reps. ✔2002 Team Lead for selling focus meetings and Team Lead for MAXALT programs for managed care.✔2000 Vioxx formulary win at Mount Sinai Hospital.